Viewing Study NCT06360471



Ignite Creation Date: 2024-05-06 @ 8:23 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06360471
Status: RECRUITING
Last Update Posted: 2024-04-16
First Post: 2024-04-07

Brief Title: Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization: The First Affiliated Hospital with Nanjing Medical University

Study Overview

Official Title: Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer Patients A Multicenter Prospective Cohort Study
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To explore whether there is a significant difference in the cumulative live birth rate and maternal and child health outcomes between cancer patients who undergo or do not undergo fertility preservation before receiving anti-tumor treatment and non-cancer patients who undergo assisted reproductive technology treatmentnatural pregnancy

This study will be conducted in the Clinical Center of Reproductive Medicine First Affiliated Hospital of Nanjing Medical University 2800 women diagnosed with malignant cancers who has desire to reproduce will be enrolled in this study

Statistical analysis of the data will be performed
Detailed Description: The number of new cancer cases among Chinese women in 2020 will be 209 million showing a trend in younger age at the time of diagnosis Incomplete statistics show that 2530 of young breast cancer patients in China Need for fertility preservation In this study we want to answer the question Does fertility preservation affect the prognosis in female cancer patients

This study will be conducted in the Clinical Center of Reproductive Medicine First Affiliated Hospital of Nanjing Medical University 2800 women diagnosed with malignant cancers who has desire to reproduce will be enrolled in this study

If a female tumor patients focusing on breast cancer hematological diseaseslymphoma gynecological tumors ovarian borderline tumors etc nasopharyngeal cancer colorectal cancer etc have a desire to reproduce in the future she would considered for enrollment After being admitted into this study according to the patientsown will she will receive long term observation or fertility preservation followed by long term observation Cumulative live birth rate perinatal and perinatal complications and offspring health of women who have or have not received fertility preservation before anti-tumor treatment and who have no tumor and who normally receive assisted reproductive technology treatmentnatural pregnancy are all recorded to assess the impact of the current new anti-tumor treatment on female fertility and offspring health

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None